How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS

Kanavos, Panos

; and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Copy

Item Type	Article
Departments	Social Policy European Institute LSE Health
Date Deposited	04 Sep 2008 15:42
URI	https://researchonline.lse.ac.uk/id/eprint/15045

Explore Further

Kanavos, Panos
Saka, Ömer R

RA Public aspects of medicine

http://www.ingentaconnect.com/content/adis/dmho (Publisher)

Full text not available from this repository.

Atom

BibTeX

OpenURL ContextObject in Span

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

Data Cite XML

EndNote

HTML Citation

METS

MODS

RIOXX2 XML

Reference Manager

Refer

ASCII Citation

Export

Downloads